Literature DB >> 27686095

The English Version of the Gilles de la Tourette Syndrome-Quality of Life Scale for Children and Adolescents (C&A-GTS-QOL).

Merina T Su1,2, Fiona McFarlane2, Andrea E Cavanna3,4,5, Cristiano Termine6, Imogen Murray2, Larissa Heidemeyer2, Isobel Heyman1,2, Tara Murphy1,2.   

Abstract

Gilles de la Tourette syndrome is a chronic neuropsychiatric disorder that can have a detrimental impact on the health-related quality of life of children with the condition. To date no patient-reported health-related quality of life measures have been developed for children and adolescents in the English language. This study validated the first disease-specific scale for the quantitative assessment of health-related quality of life in 118 children and adolescents with Gilles de la Tourette syndrome (C&A-GTS-QOL) following language adaptation from Italian to English in the United Kingdom. Standard statistical methods were used to test the psychometric properties of the rating scale. Principal component factor analyses led to the identification of six health-related quality of life domains (cognitive, copro-phenomena, psychological, physical, obsessive-compulsive, and activities of daily living), explaining 66.7% of the overall variance. The C&A-GTS-QOL demonstrated satisfactory scaling assumptions and acceptability; validity was supported by interscale correlations (range 0.2-0.7), confirmatory factor analysis, and correlation patterns with other rating scales and clinical variables.

Entities:  

Keywords:  Gilles de la Tourette; children and adolescents; health-related quality of life; validation

Mesh:

Year:  2016        PMID: 27686095     DOI: 10.1177/0883073816670083

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

1.  Clinical Correlates of Health-Related Quality of Life in Adults With Chronic Tic Disorder.

Authors:  David A Isaacs; Heather R Riordan; Daniel O Claassen
Journal:  Front Psychiatry       Date:  2021-03-10       Impact factor: 4.157

2.  Cross-cultural adaptation and psychometric evaluation of the French version of the Gilles de la Tourette Syndrome Quality of Life Scale (GTS-QOL).

Authors:  Isabelle Jalenques; Diane Cyrille; Philippe Derost; Andreas Hartmann; Sophie Lauron; Clara Jameux; Urbain Tauveron-Jalenques; Candy Guiguet-Auclair; Fabien Rondepierre
Journal:  PLoS One       Date:  2020-12-22       Impact factor: 3.240

3.  Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.

Authors:  Barbara Coffey; Joseph Jankovic; Daniel O Claassen; Joohi Jimenez-Shahed; Barry J Gertz; Elizabeth A Garofalo; David A Stamler; Maria Wieman; Juha-Matti Savola; Mark Forrest Gordon; Jessica K Alexander; Hadas Barkay; Eran Harary
Journal:  JAMA Netw Open       Date:  2021-10-01

Review 4.  European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessment.

Authors:  Kirsten R Müller-Vahl; Danielle C Cath; Natalia Szejko; Sally Robinson; Andreas Hartmann; Christos Ganos; Nanette M Debes; Liselotte Skov; Martina Haas; Renata Rizzo; Jeremy Stern; Alexander Münchau; Virginie Czernecki; Andrea Dietrich; Tara L Murphy; Davide Martino; Zsanett Tarnok; Tammy Hedderly
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-10-18       Impact factor: 4.785

5.  Assessment and Management of Tic Disorders in Pediatric Primary Care Settings.

Authors:  Mina Yadegar; Sisi Guo; Emily J Ricketts; Samuel H Zinner
Journal:  Curr Dev Disord Rep       Date:  2019-06-07

6.  The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL): A Validation in Japanese Patients.

Authors:  Ryunosuke Goto; Natsumi Matsuda; Maiko Nonaka; Yu Hamamoto; Yosuke Eriguchi; Mayu Fujiwara; Akane Suzuki; Yukari Yokoyama; Yukiko Kano
Journal:  Front Psychiatry       Date:  2022-01-03       Impact factor: 4.157

7.  Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.

Authors:  Joseph Jankovic; Barbara Coffey; Daniel O Claassen; Joohi Jimenez-Shahed; Barry J Gertz; Elizabeth A Garofalo; David A Stamler; Maria Wieman; Juha-Matti Savola; Mark Forrest Gordon; Jessica Alexander; Hadas Barkay; Eran Harary
Journal:  JAMA Netw Open       Date:  2021-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.